Orchard Therapeutics Plc (ORTX)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Orchard Therapeutics: Pioneering Breakthrough Treatment while Navigating Financial Waters
Revolutionary Paradigms: HSC Gene Therapy and Newborn Screening in Severe Neurometabolic Diseases
Remarkable Revenue Surge: Market Applauds Company*s Q3 Performance from July to September 2023
Orchard Therapeutics Plc Improves Earnings in Q1 2023, but Revenue Takes a Substantial Hit
Evanescence of Losses at ORTX during the financial fourth quarter of 2022
An amazing behavior by the company in the fiscal time-frame ending September 30 2022